RecruitingACTRN12611000218998

Effect of critical illness on blood flow to the gastrointestinal tract during feeding and the absorption of sugar in older patients

The effect of critical illness on glucose absorption, superior mesenteric artery blood flow and systemic blood pressure during intraduodenal glucose infusion in older patients


Sponsor

Jennifer Sim

Enrollment

30 participants

Start Date

Feb 21, 2011

Study Type

Interventional

Conditions

Summary

The primary purpose of the study is to investigate the effect of critical illness on blood flow to the gastrointestinal tract during feeding and the absorption of sugar in older patients. We hypothesize that the change in blood flow to the gastrointestinal tract during feeding and the absorption of sugar in ICU patients will be less than that of healthy volunteers. This may indicate a possible mechanism for malabsorption during critical illness or alternatively, when to start feeding critically ill patients via the gastrointestinal route.


Eligibility

Sex: Both males and femalesMin Age: 65 YearssMax Age: 90 Yearss

Plain Language Summary

Simplified for easier understanding

When people are critically ill in the intensive care unit (ICU), it is sometimes hard to know how well their gut (gastrointestinal tract) is absorbing nutrients from tube feeding. This study is looking at how the blood flow to the gut and sugar absorption are affected by critical illness in older patients. Understanding this could help doctors decide the best time and method to start feeding very ill patients, in order to reduce malnutrition and improve recovery. You may be eligible if: - You are 65 years or older - You are either a critically ill patient in ICU who is on a ventilator (breathing machine) and needs or is already receiving tube feeding, OR you are a healthy volunteer aged 65 or older You may NOT be eligible if: - You have had surgery on your esophagus, stomach, or duodenum (upper digestive tract) - You have had any gastrointestinal surgery during your current hospital admission - You have known diabetes mellitus - You are taking blood pressure medications (antihypertensives) - You are receiving high doses of adrenaline or noradrenaline (vasopressors) - Your BMI is above 32 kg/m² - You need very high blood pressure support Talk to your doctor about whether this trial might be right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A nasoduodenal feeding tube will be inserted through the nose and positioned in the proximal duodenum using the Cortrak device. Between t = 60 and 120 min infusion of 0.9% saline into the duodenum. At

A nasoduodenal feeding tube will be inserted through the nose and positioned in the proximal duodenum using the Cortrak device. Between t = 60 and 120 min infusion of 0.9% saline into the duodenum. At t = 120 min, an intraduodenal glucose infusion will begin (32 g glucose together with 3 g 3-oxy-methyl-D-glucose (3-OMG) in water to a total volume of 120mL, and infused over 60 minutes ~ 2 kcal/min). Participants will undergo this intervention once, after consent has been granted by the next of kin.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000218998